Increased Expression of Plakoglobin Is Associated with Upregulated MAPK and PI3K/AKT Signalling Pathways in Early Resectable Pancreatic Ductal Adenocarcinoma

Increased Expression of Plakoglobin Is Associated with Upregulated MAPK and PI3K/AKT Signalling Pathways in Early Resectable Pancreatic Ductal Adenocarcinoma

ONCOLOGY LETTERS 19: 4133-4141, 2020 Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma EKENE NWEKE1, MONDE NTWASA2, MARTIN BRAND3,4, JOHN DEVAR1,5, MARTIN SMITH1,5 and GEOFFREY CANDY1 1Department of Surgery, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng 2193; 2Department of Life and Consumer Sciences, University of South Africa, Johannesburg, Gauteng 1710; 3School of Physiology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng 2193; 4Department of Surgery, Steve Biko Academic Hospital and The University of Pretoria, Pretoria, Gauteng 0002; 5Department of Surgery, Chris Hani Baragwanath Hospital, Soweto, Johannesburg, Gauteng 1864, Republic of South Africa Received July 17, 2019; Accepted January 29, 2020 DOI: 10.3892/ol.2020.11473 Abstract. Pancreatic ductal adenocarcinoma (PDAC) is one of Introduction the most lethal cancer types, and it is associated with a 5-year survival rate of <10% due to limited early detection methods Despite the overall reduction in the number of cancer-related and ineffective therapeutic options. Thus, an improved under- deaths following improved therapeutic options, the number standing of the mechanisms involved in the early stages of of pancreatic ductal adenocarcinoma (PDAC)-related deaths PDAC tumorigenesis is crucial in order to identify potential continues to increase; it is associated with a median overall novel diagnostic and therapeutic targets. The most common survival of <1 year and <10% survival at 5 years (1). Thus, an signalling aberrations in PDAC occur in the Wnt/Notch signal- improved understanding of the mechanisms mediating PDAC ling pathway, as well as within the epidermal growth factor tumourigenesis is required. receptor (EGFR) pathway and its associated ligands, EGF and Plakoglobin, also known as γ-catenin, is a member of the transforming growth factor-β. In addition, the RAS family catenin family and is an important component of desmosomes of oncogenes, which act downstream of EGFR, are found and adherens junctions in mammalian cells, where it facilitates mutated in most pancreatic cancer samples. Plakoglobin, a cell-cell adhesion by linking desmosomal cadherins to the component of the EGFR signalling pathway, serves an impor- cytoskeleton (2,3). Plakoglobin can also be found localised in tant role in normal cell adhesion; however, its role in PDAC the nucleus, where it exerts nuclear functions, such as inhibiting is largely unknown. The present study used transcriptome the Wnt/β-catenin signalling pathway through regulating the sequencing and focussed proteome microarrays to identify transcription of specific components within the pathway (4,5). dysregulated genes and proteins in PDAC. The presence of Nonetheless, the role that plakoglobin serves in tumorigenesis upregulated plakoglobin expression levels was identified as a is disputed; whilst the majority of previous studies reported distinguishing feature between the PDAC microenvironment that plakoglobin suppressed tumour growth, others observed and normal pancreatic tissue. Furthermore, plakoglobin was that plakoglobin exhibited pro-oncogenic features (5-9). For demonstrated to be associated with the differential upregula- example, the overexpression of plakoglobin in SV40-transformed tion of the PI3K/AKT and MAPK signalling pathways in the 3T3 cells suppressed tumour formation upon transplantation tumour microenvironment, which suggested that it may serve into syngeneic mice, and upon co-transfection of plakoglobin an important role in PDAC tumourigenesis. with N-cadherin, this tumour suppressive effect was consider- ably more effective than plakoglobin overexpression alone. Similarly, the overexpression of plakoglobin in a human renal carcinoma cell line that lacked the expression of cadherins or β-catenin also suppressed tumour formation in nude mice (6). In Correspondence to: Professor Monde Ntwasa, Department of Life addition, plakoglobin reportedly affected several downstream and Consumer Sciences, University of South Africa, Calabash Building signalling molecules involved in tumour suppressive pathways; 211, 28 Pioneer Avenue, Florida Park, Cnr Christiaan de Wet and Pioneer Roads, Johannesburg, Gauteng 1710, Republic of South Africa plakoglobin reportedly regulated the expression and stability E-mail: [email protected] of the metastasis suppressor protein, Nm23, as well as the p53-regulated tumour suppressor, 14-3-3σ (4,7,10). On the other Key words: pancreatic ductal adenocarcinoma, γ-catenin, JUP, hand, a recent study demonstrated that high expression levels gene expression, P13K/AKT, MAPK signalling of plakoglobin promoted metastasis in invasive micropapillary carcinoma of the breast by promoting tumour cluster formation through activating PI3K/AKT/Bcl-2 signalling (9). 4134 NWEKE et al: PLAKOGLOBIN UPREGULATION IN EARLY PDAC As a closely related homologue of β-catenin, a crucial tran- paired non‑malignant pancreatic tissue samples (≥2 cm away scriptional regulator of the canonical Wnt signalling pathway, from the tumour) were obtained from nine patients who under- plakoglobin shares structural and functional similarities with went a pancreaticoduodenectomy for clinically resectable, β-catenin (11). It has previously been demonstrated that plako- early stage PDAC (Table I). It is important to note that patients globin competes with β-catenin, which leads to aberrations in recruited for this study were representative of different clinical Wnt signalling; both β-catenin and plakoglobin were observed stages, thus observations made within the study were attributed to bind to the transcriptional co-activator, transcription factor to PDAC in general. Biopsies were stored in 1 ml RNAlater 7-like 2 (also known as Tcf4), although the latter bound with RNA stabilization reagent (cat. no. 76106; Qiagen, Inc.) and stronger affinity, and their co‑expression led to the overall subsequently homogenized in 600 µl AllPrep DNA/RNA Mini net inhibition of Wnt signalling (12,13). Plakoglobin was also kit lysis buffer (cat. no. 80204; Qiagen, Inc.) using a TissueRuptor discovered to activate T-cell factor/lymphocyte enhancer (cat. no. 9001272; Qiagen, Inc.). factor (TCF/LEF) transcriptional activity in the absence of β-catenin (11), and the decrease in plakoglobin expression RNA extraction. Total RNA was extracted from PDAC tumour levels correlated with poorer prognosis in malignancies such tissue and non-malignant pancreatic tissue using an AllPrep as non-small lung cancer (14). DNA/RNA Mini kit (cat. no. 80201; Qiagen, Inc.) and DNase PDAC originates from both acinar and ductal cells and the digestion was performed using a DNase kit (cat. no. AMPD1; well-described mechanism of tumorigenesis involves the early Sigma-Aldrich; Merck KGaA), according to the manufac- genetic alteration in the oncogene, K‑RAS, whereby the expres- turers' protocols. Total RNA was quantified using a NanoDrop sion of K‑RASG12D is thought to induce the disease (15-17). ND-1000 UV spectrophotometer and a ratio of absorbance at However, studies in mice models have demonstrated that the 260 and 280 nm of >1.8 was observed in all samples. expression of KRASG12D in mature pancreatic acinar cells was insufficient to induce the PDAC precursor, pancreatic intraepi- Gene expression profiling using RNA sequencing. Total RNA thelial neoplasia (18), and that the accumulation of mutations in extracted from tissue samples obtained from patients 7 and 8 P16, TP53 and SMAD4 (15-17) are also required for the cancer (Table I) were treated with DNase to remove genomic DNA. to progress. Thus, nodal regulators of cellular responses have The NEB Next rRNA Depletion kit (human/mouse/rat) (New been proposed as potential strategies for inhibiting PDAC forma- England Biolabs Inc.; cat no. E6310S) was subsequently used tion (18). It was noted in a previous study that compared with to remove the ribosomal RNA from the samples. The mRNA pancreatic acinar cells, ductal cell developed more rapidly into was converted into cDNA using the Ultra RNA Library PDAC in the presence of K‑RAS and TP53 mutations (19). Thus, Prep kit (New England Biolabs Inc.; cat no. 7530L) and the discovery of other mechanisms dependent or independent of subsequently sequenced using the Illumina MiSeq system. K‑RAS is required to understand the induction, development and The CLC Genomics Workbench version 11 software (www. progression of early-stage PDAC. Genetic analysis of 24 patients qiagenbioinformatics.com/products/clc-genomics-workbench) with advanced PDAC revealed that twelve core signalling path- was used for data normalization and differential gene analysis, ways were dysregulated in 67% of PDAC tumours, including with HG19 serving as the reference genome. Hedgehog, Wnt/Notch, K-RAS, small GTPase, transforming growth factor (TGF)-β and integrin signalling. Notably, despite Biomarker filtering analysis. The biomarker filtering the heterogeneity of these altered genes amongst the patients, all analysis tool available in the Ingenuity pathway analysis PDAC tumours demonstrated alterations in the Wnt/Notch and (IPA) software v01-08 (https://www.qiagenbioinformatics. Hedgehog signalling pathways (20). Further investigations have com/products/ingenuity-pathway-analysis/ was used to observed the induction of several mitogenic signalling pathways identify novel potential biomarkers. Microsoft Excel files by various growth factors in PDAC

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    9 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us